Summary
- Current Price
- As of today, ENTO price is $2.85, with unknown change on
- Current Price All-Time High
- ENTO price is currently -100.00% below its historical high of $705,600.00 set on
- Market Cap
- ENTO current market cap is $10M, up +299.09% over the past 365 days
- PE Ratio
- ENTO PE ratio is unknown
- Revenue
- ENTO current annual revenue is $0.00, unchanged year-over-year
- Next Earnings
- As of today, the next earnings release for ENTO has not been scheduled
Profile
| Metric | Value |
|---|---|
| Full Name | Entero Therapeutics, Inc. |
| Ticker | NASDAQ: ENTO |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | enterothera.com |
| Employees | 2 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| $2.85 | ||
| Price, 1D Change | - | |
| $10M | ||
| - | ||
| - | ||
| 0.37 | ||
| $0 | ||
| Revenue, 1Y Change | 0.00% | |
| -$15.98 | ||
| EPS, 1Y Change | +66.62% |
Chart
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | N/A | |
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:3 | |
| Next Split | N/A | N/A |
| Last Ticker Change | FWBI | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$15.98 | ||
| EPS Estimate | N/A | -$1.52 |
| EPS Est. Change | N/A | +90.49% |
| $0.00 | ||
| Revenue Estimate | N/A | - |
| Revenue Est. Change | N/A | - |
| $2.85 | ||
| Price Target | - | - |
| Price Tgt. Change | - | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | -$15.98 | - | |
| -$1.52 | N/A | +90.49% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| - | N/A | - |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| +88.12% | ||
| -98.70% | ||
| +299.09% | ||
| +163.92% | ||
| 0.00% | ||
| 0.00% | ||
| +66.62% | ||
| +99.96% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| $2.85 | ||
| $2.60 | ||
| SMA 200 vs Price | -8.82% | |
| $3.23 | ||
| SMA 50 vs Price | +13.34% | |
| 0.37 | ||
| $0.47 | ||
| 40.49 | ||
| 125.69% | ||
| 147.96% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $0.00 | ||
| -$15.98 | ||
| -$48.90K | ||
| - | ||
| -$15.62M | ||
| - | ||
| -$15.62M | ||
| - | ||
| -$15.57M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.00 | ||
| 3.03 | ||
| 3.03 | ||
| - | ||
| - | ||
| -2.93 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| - | ||
| 0.42 | ||
| -2.20 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| -$3.88M | ||
| $163.50K | ||
| $85.41M | ||
| $83.48M | ||
| $27.61M | ||
| $27.55M | ||
| $140.50K | ||
| $81.50K | ||
| $2.96M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $15.62M | ||
| $15.57M | ||
| $48.90K | ||
| $0.00 | ||
| $48.90K | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$9.22M | ||
| $88.20K | ||
| $5.58M | ||
| $0.00 | ||
| -$9.22M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Roth MKM | → | |
| Roth MKM | → |
Analyst sentiment
Institutional ownership
Screeners with ENTO
FAQ
What is the ticker symbol for Entero Therapeutics, Inc.?
The ticker symbol for Entero Therapeutics, Inc. is NASDAQ:ENTO
Does Entero Therapeutics, Inc. pay dividends?
No, Entero Therapeutics, Inc. does not pay dividends
What sector is Entero Therapeutics, Inc. in?
Entero Therapeutics, Inc. is in the Healthcare sector
What industry is Entero Therapeutics, Inc. in?
Entero Therapeutics, Inc. is in the Biotechnology industry
What country is Entero Therapeutics, Inc. based in?
Entero Therapeutics, Inc. is headquartered in United States
When did Entero Therapeutics, Inc. go public?
Entero Therapeutics, Inc. initial public offering (IPO) was on October 11, 2016
Is Entero Therapeutics, Inc. in the S&P 500?
No, Entero Therapeutics, Inc. is not included in the S&P 500 index
Is Entero Therapeutics, Inc. in the NASDAQ 100?
No, Entero Therapeutics, Inc. is not included in the NASDAQ 100 index
Is Entero Therapeutics, Inc. in the Dow Jones?
No, Entero Therapeutics, Inc. is not included in the Dow Jones index
When was Entero Therapeutics, Inc. last earnings report?
Entero Therapeutics, Inc.'s most recent earnings report was on October 21, 2025
When does Entero Therapeutics, Inc. report earnings?
The date for Entero Therapeutics, Inc.'s next earnings report has not been announced yet
Data Sources & References
- ENTO Official Website www.enterothera.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1604191/000141057825000618/0001410578-25-000618-index.htm
- ENTO Profile on Yahoo Finance finance.yahoo.com/quote/ENTO
- ENTO Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/ento